934527-94-3

Upstream product

• 2213-63-0 2,3-dichloroquinoxaline 
• 731815-55-7 (N-(3-chloroquinoxalin-2-yl)-3-nitrobenzenesulfonamide) 
• 586-10-7 3-methoxy-5-nitroaniline 

Downstream Products

• 934526-57-5 3-amino-N-(3-(3-amino-5-methoxy-phenylamino)quinoxalin-2-yl)benzenesulfonamide 
• 934531-97-2 3-amino-N-(3-(3-methoxy-5-nitro-phenylamino)quinoxalin-2-yl)benzenesulfonamidemide 

Relevant academic research and scientific papers

METHODS OF TREATING BY INHIBITING WITH QUINAXOLINE INHIBITORS OF PI3K-ALPHA

The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments.

METHODS OF USING PI3K AND MEK MODULATORS

The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K.

PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS AND METHODS OF THEIR USE

The present invention comprises small molecule inhibitors of phosphatidylinositol 3-kinase (PI3K), which is associated with a number of malignancies such as ovarian cancer, cervical cancer, breast cancer, colon cancer, rectal cancer, and glioblastomas, am